Michael Gelband’s Aehr Test Systems AEHR Stock Holding History

Michael Gelband’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-93,622	Closed	-$3.47M	–	1524
2026 Q1	$3.47M	Buy	+93,622	New	+$2.99M	0.03%	561
2025 Q4	–	Sell	-178,658	Closed	-$5.38M	–	1488
2025 Q3	$5.38M	Buy	+178,658	New	+$3.87M	0.06%	383
2024 Q3	–	Sell	-82,529	Closed	-$922K	–	1576
2024 Q2	$922K	Buy	+82,529	New	+$962K	0.01%	1045
2022 Q2	–	Sell	-42,444	Closed	-$431K	–	1889
2022 Q1	$431K	Buy	+42,444	New	+$543K	0.01%	1613

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Michael Gelband's AEHR Position: Q2 2026 in Review

Michael Gelband sold out of Aehr Test Systems (AEHR) in Q2 2026, closing a stake of 93,622 shares — an estimated $3.47M sold.

Michael Gelband first reported a position in AEHR in Q1 2022 and held it in 4 quarters. The position peaked at $5.38M in Q3 2025. 261 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Michael Gelband reported no remaining Aehr Test Systems position as of Q2 2026 after selling out during the quarter.
Michael Gelband sold 93,622 Aehr Test Systems shares in Q2 2026, an estimated $3.47M.
Michael Gelband first reported a position in Aehr Test Systems in Q1 2022 and held it in 4 quarters.
Michael Gelband's Aehr Test Systems position peaked at $5.38M in Q3 2025.
261 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.